Immune modulation underpins the anti-cancer activity of HDAC inhibitors.
Blaszczak W, Liu G, Zhu H, Barczak W, Shrestha A, Albayrak G, Zheng S, Kerr D, Samsonova A, La Thangue NB.
Blaszczak W, et al.
Mol Oncol. 2021 Dec;15(12):3280-3298. doi: 10.1002/1878-0261.12953. Epub 2021 May 1.
Mol Oncol. 2021.
PMID: 33773029
Free PMC article.